Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge
- PMID: 33756229
- PMCID: PMC7953440
- DOI: 10.1016/j.intimp.2021.107579
Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge
Abstract
Objective: Re-positivity of SARS-CoV-2 in discharged COVID-19 patients have been reported; however, early risk factors for SARS-CoV-2 re-positivity evaluation are limited.
Methods: This is a prospective study, a total of 145 COVID-19 patients were treated and all discharged according to the guideline criteria by Mar 11th 2020. After discharge, clinical visits and viral RT-PCR tests by the second and fourth week follow-up were carried-out. Patient demographic and clinical characteristics and laboratory data on admission and discharge were retrieved, and predictive factors for SARS-CoV-2 re-positivity were analyzed.
Results: 13 out of 145 (9.0%) COVID-19 patients were confirmed re-positivity of SARS-CoV-2 by RT-PCR test. The median interval between disease onset to recurrence was 38 days. SARS-CoV-2 re-positive cases were of significantly longer virus shedding duration, notably higher body temperature, heart rate and lower TNF-α and IgG levels on admission. Covariate logistic regression analysis revealed virus shedding duration and IgG levels are independent risk factors for SARS-CoV-2 return positive after discharge.
Conclusion: Longer viral shedding duration and lower IgG levels are risk factors for re-positivity of SARS-CoV-2 for discharged COVID-19 patients.
Keywords: COVID-19; Re-positivity; Risk factor; SARS-CoV-2.
Copyright © 2021 Elsevier B.V. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
A comparative study of virus nucleic acid re-positive and non-re-positive patients infected with SARS-CoV-2 Delta variant strain in the Ningxia Hui Autonomous Region.Front Public Health. 2022 Dec 13;10:1023797. doi: 10.3389/fpubh.2022.1023797. eCollection 2022. Front Public Health. 2022. PMID: 36582384 Free PMC article.
-
Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.Clin Exp Med. 2021 Aug;21(3):361-367. doi: 10.1007/s10238-021-00687-y. Epub 2021 Feb 4. Clin Exp Med. 2021. PMID: 33543353 Free PMC article.
-
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.Nat Commun. 2020 Nov 27;11(1):6044. doi: 10.1038/s41467-020-19943-y. Nat Commun. 2020. PMID: 33247152 Free PMC article.
-
Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.AIDS Rev. 2021 Jun 3;23(3):153-163. doi: 10.24875/AIDSRev.21000023. AIDS Rev. 2021. PMID: 34082440 Review.
-
Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review.Eur J Clin Microbiol Infect Dis. 2021 Jan;40(1):13-25. doi: 10.1007/s10096-020-04088-z. Epub 2020 Oct 28. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33113040 Free PMC article. Review.
Cited by
-
A comparative study of virus nucleic acid re-positive and non-re-positive patients infected with SARS-CoV-2 Delta variant strain in the Ningxia Hui Autonomous Region.Front Public Health. 2022 Dec 13;10:1023797. doi: 10.3389/fpubh.2022.1023797. eCollection 2022. Front Public Health. 2022. PMID: 36582384 Free PMC article.
-
Clinical Characteristics in Patients with Redetected Positive RNA Test After Recovery from Foreign-Imported COVID-19 Cases in Xi'an, China.Infect Drug Resist. 2022 Jun 24;15:3295-3307. doi: 10.2147/IDR.S371088. eCollection 2022. Infect Drug Resist. 2022. PMID: 35774303 Free PMC article.
-
Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis.Viruses. 2021 Apr 30;13(5):809. doi: 10.3390/v13050809. Viruses. 2021. PMID: 33946311 Free PMC article.
-
Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection.Front Immunol. 2021 Dec 6;12:788769. doi: 10.3389/fimmu.2021.788769. eCollection 2021. Front Immunol. 2021. PMID: 34938296 Free PMC article. Review.
-
Metabolic Syndrome Is Associated with Poor Omicron Infection Prognosis While Inactivated Vaccine Improves the Outcome of Coronavirus Disease 2019 among Chinese Inhabitants: A Retrospective Observational Study from a Chinese Municipality.Vaccines (Basel). 2023 Sep 30;11(10):1554. doi: 10.3390/vaccines11101554. Vaccines (Basel). 2023. PMID: 37896957 Free PMC article.
References
-
- Hong L.-X., Lin A., He Z.-B., Zhao H.-H., Zhang J.-G., Zhang C., Ying L.-J., Ge Z.-M., Zhang X., Han Q.-Y., Chen Q.-Y., Ye Y.-H., Zhu J.-S., Chen H.-X., Yan W.-H. Mask wearing in pre-symptomatic patients prevents SARS-CoV-2 transmission: An epidemiological analysis. Travel Med. Infect. Dis. 2020;36:101803. doi: 10.1016/j.tmaid.2020.101803. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous